세계의 항생제 의약품 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)

The global market for Antibiotic Drug was estimated to be worth US$ 52552 million in 2024 and is forecast to a readjusted size of US$ 65833 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.

Antibiotics are a class of drugs used to prevent and treat bacterial infections by inhibiting the growth or killing bacteria. They work by targeting specific components of bacterial cells, such as cell walls, protein synthesis, or DNA replication, which are essential for bacterial survival and replication. Antibiotics are widely used in the treatment of infections like pneumonia, urinary tract infections, skin infections, and tuberculosis. They can be administered in various forms, including oral tablets, intravenous injections, and topical creams, depending on the severity and location of the infection. Over time, antibiotics have become a cornerstone of modern medicine, helping to save countless lives by controlling bacterial infections.

The antibiotics drugs market is driven by the growing global burden of bacterial infections, particularly in developing regions where access to healthcare may be limited. Antibiotics are essential for treating a wide range of infections, from minor illnesses like respiratory infections to more severe diseases such as sepsis and tuberculosis. The increasing prevalence of chronic diseases, hospital-acquired infections, and the rising geriatric population are also contributing to the demand for antibiotics. Additionally, advancements in antibiotic formulations, including the development of new broad-spectrum antibiotics and the introduction of novel delivery systems, are helping to address emerging resistant strains of bacteria, further fueling market growth.

However, the antibiotics market faces significant challenges, primarily due to the rising threat of antibiotic resistance. Overuse and misuse of antibiotics in both humans and animals have accelerated the development of resistant bacteria, which can make existing treatments less effective. This resistance has led to the urgent need for new antibiotics, yet the pace of antibiotic discovery has slowed due to scientific and economic barriers. The high cost of research and development, coupled with regulatory hurdles and the shorter patent life of antibiotics compared to other drugs, also limits the investment in this sector. Furthermore, the increasing preference for alternative treatments and concerns over the environmental impact of antibiotic residues are influencing market dynamics.

This report aims to provide a comprehensive presentation of the global market for Antibiotic Drug, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Antibiotic Drug by region & country, by Type, and by Application.

The Antibiotic Drug market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibiotic Drug.

Market Segmentation

By Company

• GSK
• Pfizer
• Merck & Co
• Sandoz
• Sumitomo Pharma
• Fresenius
• AbbVie
• Hailin Pharmaceuticals
• Bausch Health
• Southwest Pharmaceuticals
• Zhuhai United Pharmaceuticals
• Qilu Pharmaceuticals
• China Resources Sanjiu Pharmaceuticals
• Shenzhen Xinlitai Pharmaceuticals
• Shanghai Modern Pharmaceuticals
• North China Pharmaceuticals
• Sun Pharmaceuticals
• Hikma Pharmaceuticals
• Shijiazhuang Pharmaceutical Group
• Resun Pharmaceuticals

Segment by Type

• Oral
• Injection
• Other

Segment by Drug

• B-lactams
• Tetracyclines
• Macrolides
• Aminoglycosides
• Peptides
• Quinolones
• Other

Segment by Application

• Hospitals
• Retail Pharmacy
• Other

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Antibiotic Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Antibiotic Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Antibiotic Drug in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Antibiotic Drug Product Introduction
• 1.2 Global Antibiotic Drug Market Size Forecast (2020-2031)
• 1.3 Antibiotic Drug Market Trends & Drivers
  • 1.3.1 Antibiotic Drug Industry Trends
  • 1.3.2 Antibiotic Drug Market Drivers & Opportunity
  • 1.3.3 Antibiotic Drug Market Challenges
  • 1.3.4 Antibiotic Drug Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Antibiotic Drug Players Revenue Ranking (2024)
• 2.2 Global Antibiotic Drug Revenue by Company (2020-2025)
• 2.3 Key Companies Antibiotic Drug Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies Antibiotic Drug Product Offered
• 2.5 Key Companies Time to Begin Mass Production of Antibiotic Drug
• 2.6 Antibiotic Drug Market Competitive Analysis
  • 2.6.1 Antibiotic Drug Market Concentration Rate (2020-2025)
  • 2.6.2 Global 5 and 10 Largest Companies by Antibiotic Drug Revenue in 2024
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibiotic Drug as of 2024)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Oral
  • 3.1.2 Injection
  • 3.1.3 Other
• 3.2 Global Antibiotic Drug Sales Value by Type
  • 3.2.1 Global Antibiotic Drug Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Antibiotic Drug Sales Value, by Type (2020-2031)
  • 3.2.3 Global Antibiotic Drug Sales Value, by Type (%) (2020-2031)

4 Segmentation by Drug

• 4.1 Introduction by Drug
  • 4.1.1 B-lactams
  • 4.1.2 Tetracyclines
  • 4.1.3 Macrolides
  • 4.1.4 Aminoglycosides
  • 4.1.5 Peptides
  • 4.1.6 Quinolones
  • 4.1.7 Other
• 4.2 Global Antibiotic Drug Sales Value by Drug
  • 4.2.1 Global Antibiotic Drug Sales Value by Drug (2020 VS 2024 VS 2031)
  • 4.2.2 Global Antibiotic Drug Sales Value, by Drug (2020-2031)
  • 4.2.3 Global Antibiotic Drug Sales Value, by Drug (%) (2020-2031)

5 Segmentation by Application

• 5.1 Introduction by Application
  • 5.1.1 Hospitals
  • 5.1.2 Retail Pharmacy
  • 5.1.3 Other
• 5.2 Global Antibiotic Drug Sales Value by Application
  • 5.2.1 Global Antibiotic Drug Sales Value by Application (2020 VS 2024 VS 2031)
  • 5.2.2 Global Antibiotic Drug Sales Value, by Application (2020-2031)
  • 5.2.3 Global Antibiotic Drug Sales Value, by Application (%) (2020-2031)

6 Segmentation by Region

• 6.1 Global Antibiotic Drug Sales Value by Region
  • 6.1.1 Global Antibiotic Drug Sales Value by Region: 2020 VS 2024 VS 2031
  • 6.1.2 Global Antibiotic Drug Sales Value by Region (2020-2025)
  • 6.1.3 Global Antibiotic Drug Sales Value by Region (2026-2031)
  • 6.1.4 Global Antibiotic Drug Sales Value by Region (%), (2020-2031)
• 6.2 North America
  • 6.2.1 North America Antibiotic Drug Sales Value, 2020-2031
  • 6.2.2 North America Antibiotic Drug Sales Value by Country (%), 2024 VS 2031
• 6.3 Europe
  • 6.3.1 Europe Antibiotic Drug Sales Value, 2020-2031
  • 6.3.2 Europe Antibiotic Drug Sales Value by Country (%), 2024 VS 2031
• 6.4 Asia Pacific
  • 6.4.1 Asia Pacific Antibiotic Drug Sales Value, 2020-2031
  • 6.4.2 Asia Pacific Antibiotic Drug Sales Value by Region (%), 2024 VS 2031
• 6.5 South America
  • 6.5.1 South America Antibiotic Drug Sales Value, 2020-2031
  • 6.5.2 South America Antibiotic Drug Sales Value by Country (%), 2024 VS 2031
• 6.6 Middle East & Africa
  • 6.6.1 Middle East & Africa Antibiotic Drug Sales Value, 2020-2031
  • 6.6.2 Middle East & Africa Antibiotic Drug Sales Value by Country (%), 2024 VS 2031

7 Segmentation by Key Countries/Regions

• 7.1 Key Countries/Regions Antibiotic Drug Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 7.2 Key Countries/Regions Antibiotic Drug Sales Value, 2020-2031
• 7.3 United States
  • 7.3.1 United States Antibiotic Drug Sales Value, 2020-2031
  • 7.3.2 United States Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
  • 7.3.3 United States Antibiotic Drug Sales Value by Application, 2024 VS 2031
• 7.4 Europe
  • 7.4.1 Europe Antibiotic Drug Sales Value, 2020-2031
  • 7.4.2 Europe Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
  • 7.4.3 Europe Antibiotic Drug Sales Value by Application, 2024 VS 2031
• 7.5 China
  • 7.5.1 China Antibiotic Drug Sales Value, 2020-2031
  • 7.5.2 China Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
  • 7.5.3 China Antibiotic Drug Sales Value by Application, 2024 VS 2031
• 7.6 Japan
  • 7.6.1 Japan Antibiotic Drug Sales Value, 2020-2031
  • 7.6.2 Japan Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
  • 7.6.3 Japan Antibiotic Drug Sales Value by Application, 2024 VS 2031
• 7.7 South Korea
  • 7.7.1 South Korea Antibiotic Drug Sales Value, 2020-2031
  • 7.7.2 South Korea Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
  • 7.7.3 South Korea Antibiotic Drug Sales Value by Application, 2024 VS 2031
• 7.8 Southeast Asia
  • 7.8.1 Southeast Asia Antibiotic Drug Sales Value, 2020-2031
  • 7.8.2 Southeast Asia Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
  • 7.8.3 Southeast Asia Antibiotic Drug Sales Value by Application, 2024 VS 2031
• 7.9 India
  • 7.9.1 India Antibiotic Drug Sales Value, 2020-2031
  • 7.9.2 India Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
  • 7.9.3 India Antibiotic Drug Sales Value by Application, 2024 VS 2031

8 Company Profiles

• 8.1 GSK
  • 8.1.1 GSK Profile
  • 8.1.2 GSK Main Business
  • 8.1.3 GSK Antibiotic Drug Products, Services and Solutions
  • 8.1.4 GSK Antibiotic Drug Revenue (US$ Million) & (2020-2025)
  • 8.1.5 GSK Recent Developments
• 8.2 Pfizer
  • 8.2.1 Pfizer Profile
  • 8.2.2 Pfizer Main Business
  • 8.2.3 Pfizer Antibiotic Drug Products, Services and Solutions
  • 8.2.4 Pfizer Antibiotic Drug Revenue (US$ Million) & (2020-2025)
  • 8.2.5 Pfizer Recent Developments
• 8.3 Merck & Co
  • 8.3.1 Merck & Co Profile
  • 8.3.2 Merck & Co Main Business
  • 8.3.3 Merck & Co Antibiotic Drug Products, Services and Solutions
  • 8.3.4 Merck & Co Antibiotic Drug Revenue (US$ Million) & (2020-2025)
  • 8.3.5 Merck & Co Recent Developments
• 8.4 Sandoz
  • 8.4.1 Sandoz Profile
  • 8.4.2 Sandoz Main Business
  • 8.4.3 Sandoz Antibiotic Drug Products, Services and Solutions
  • 8.4.4 Sandoz Antibiotic Drug Revenue (US$ Million) & (2020-2025)
  • 8.4.5 Sandoz Recent Developments
• 8.5 Sumitomo Pharma
  • 8.5.1 Sumitomo Pharma Profile
  • 8.5.2 Sumitomo Pharma Main Business
  • 8.5.3 Sumitomo Pharma Antibiotic Drug Products, Services and Solutions
  • 8.5.4 Sumitomo Pharma Antibiotic Drug Revenue (US$ Million) & (2020-2025)
  • 8.5.5 Sumitomo Pharma Recent Developments
• 8.6 Fresenius
  • 8.6.1 Fresenius Profile
  • 8.6.2 Fresenius Main Business
  • 8.6.3 Fresenius Antibiotic Drug Products, Services and Solutions
  • 8.6.4 Fresenius Antibiotic Drug Revenue (US$ Million) & (2020-2025)
  • 8.6.5 Fresenius Recent Developments
• 8.7 AbbVie
  • 8.7.1 AbbVie Profile
  • 8.7.2 AbbVie Main Business
  • 8.7.3 AbbVie Antibiotic Drug Products, Services and Solutions
  • 8.7.4 AbbVie Antibiotic Drug Revenue (US$ Million) & (2020-2025)
  • 8.7.5 AbbVie Recent Developments
• 8.8 Hailin Pharmaceuticals
  • 8.8.1 Hailin Pharmaceuticals Profile
  • 8.8.2 Hailin Pharmaceuticals Main Business
  • 8.8.3 Hailin Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • 8.8.4 Hailin Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
  • 8.8.5 Hailin Pharmaceuticals Recent Developments
• 8.9 Bausch Health
  • 8.9.1 Bausch Health Profile
  • 8.9.2 Bausch Health Main Business
  • 8.9.3 Bausch Health Antibiotic Drug Products, Services and Solutions
  • 8.9.4 Bausch Health Antibiotic Drug Revenue (US$ Million) & (2020-2025)
  • 8.9.5 Bausch Health Recent Developments
• 8.10 Southwest Pharmaceuticals
  • 8.10.1 Southwest Pharmaceuticals Profile
  • 8.10.2 Southwest Pharmaceuticals Main Business
  • 8.10.3 Southwest Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • 8.10.4 Southwest Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
  • 8.10.5 Southwest Pharmaceuticals Recent Developments
• 8.11 Zhuhai United Pharmaceuticals
  • 8.11.1 Zhuhai United Pharmaceuticals Profile
  • 8.11.2 Zhuhai United Pharmaceuticals Main Business
  • 8.11.3 Zhuhai United Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • 8.11.4 Zhuhai United Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
  • 8.11.5 Zhuhai United Pharmaceuticals Recent Developments
• 8.12 Qilu Pharmaceuticals
  • 8.12.1 Qilu Pharmaceuticals Profile
  • 8.12.2 Qilu Pharmaceuticals Main Business
  • 8.12.3 Qilu Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • 8.12.4 Qilu Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
  • 8.12.5 Qilu Pharmaceuticals Recent Developments
• 8.13 China Resources Sanjiu Pharmaceuticals
  • 8.13.1 China Resources Sanjiu Pharmaceuticals Profile
  • 8.13.2 China Resources Sanjiu Pharmaceuticals Main Business
  • 8.13.3 China Resources Sanjiu Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • 8.13.4 China Resources Sanjiu Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
  • 8.13.5 China Resources Sanjiu Pharmaceuticals Recent Developments
• 8.14 Shenzhen Xinlitai Pharmaceuticals
  • 8.14.1 Shenzhen Xinlitai Pharmaceuticals Profile
  • 8.14.2 Shenzhen Xinlitai Pharmaceuticals Main Business
  • 8.14.3 Shenzhen Xinlitai Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • 8.14.4 Shenzhen Xinlitai Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
  • 8.14.5 Shenzhen Xinlitai Pharmaceuticals Recent Developments
• 8.15 Shanghai Modern Pharmaceuticals
  • 8.15.1 Shanghai Modern Pharmaceuticals Profile
  • 8.15.2 Shanghai Modern Pharmaceuticals Main Business
  • 8.15.3 Shanghai Modern Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • 8.15.4 Shanghai Modern Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
  • 8.15.5 Shanghai Modern Pharmaceuticals Recent Developments
• 8.16 North China Pharmaceuticals
  • 8.16.1 North China Pharmaceuticals Profile
  • 8.16.2 North China Pharmaceuticals Main Business
  • 8.16.3 North China Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • 8.16.4 North China Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
  • 8.16.5 North China Pharmaceuticals Recent Developments
• 8.17 Sun Pharmaceuticals
  • 8.17.1 Sun Pharmaceuticals Profile
  • 8.17.2 Sun Pharmaceuticals Main Business
  • 8.17.3 Sun Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • 8.17.4 Sun Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
  • 8.17.5 Sun Pharmaceuticals Recent Developments
• 8.18 Hikma Pharmaceuticals
  • 8.18.1 Hikma Pharmaceuticals Profile
  • 8.18.2 Hikma Pharmaceuticals Main Business
  • 8.18.3 Hikma Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • 8.18.4 Hikma Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
  • 8.18.5 Hikma Pharmaceuticals Recent Developments
• 8.19 Shijiazhuang Pharmaceutical Group
  • 8.19.1 Shijiazhuang Pharmaceutical Group Profile
  • 8.19.2 Shijiazhuang Pharmaceutical Group Main Business
  • 8.19.3 Shijiazhuang Pharmaceutical Group Antibiotic Drug Products, Services and Solutions
  • 8.19.4 Shijiazhuang Pharmaceutical Group Antibiotic Drug Revenue (US$ Million) & (2020-2025)
  • 8.19.5 Shijiazhuang Pharmaceutical Group Recent Developments
• 8.20 Resun Pharmaceuticals
  • 8.20.1 Resun Pharmaceuticals Profile
  • 8.20.2 Resun Pharmaceuticals Main Business
  • 8.20.3 Resun Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • 8.20.4 Resun Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
  • 8.20.5 Resun Pharmaceuticals Recent Developments

9 Industry Chain Analysis

• 9.1 Antibiotic Drug Industrial Chain
• 9.2 Antibiotic Drug Upstream Analysis
  • 9.2.1 Key Raw Materials
  • 9.2.2 Raw Materials Key Suppliers
  • 9.2.3 Manufacturing Cost Structure
• 9.3 Midstream Analysis
• 9.4 Downstream Analysis (Customers Analysis)
• 9.5 Sales Model and Sales Channels
  • 9.5.1 Antibiotic Drug Sales Model
  • 9.5.2 Sales Channel
  • 9.5.3 Antibiotic Drug Distributors

10 Research Findings and Conclusion

11 Appendix

• 11.1 Research Methodology
  • 11.1.1 Methodology/Research Approach
    • 11.1.1.1 Research Programs/Design
    • 11.1.1.2 Market Size Estimation
    • 11.1.1.3 Market Breakdown and Data Triangulation
  • 11.1.2 Data Source
    • 11.1.2.1 Secondary Sources
    • 11.1.2.2 Primary Sources
• 11.2 Author Details
• 11.3 Disclaimer